265 related articles for article (PubMed ID: 27862031)
1. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
2. A review of muscle- and performance-based assessment instruments in DM1.
Symonds T; Campbell P; Randall JA
Muscle Nerve; 2017 Jul; 56(1):78-85. PubMed ID: 27862025
[TBL] [Abstract][Full Text] [Related]
3. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
4. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
[TBL] [Abstract][Full Text] [Related]
8. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
[TBL] [Abstract][Full Text] [Related]
9. French translation and cross-cultural adaptation of The Myotonic Dystrophy Health Index.
Gagnon C; Tremblay M; CôTé I; Heatwole C
Muscle Nerve; 2018 Apr; 57(4):686-689. PubMed ID: 29053894
[TBL] [Abstract][Full Text] [Related]
10. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.
Romigi A; Franco V; Placidi F; Liguori C; Rastelli E; Vitrani G; Centonze D; Massa R
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):102. PubMed ID: 30382420
[TBL] [Abstract][Full Text] [Related]
11. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of Daytime Sleepiness and Fatigue Scales in Myotonic Dystrophy Type 1.
Laberge L; Gallais B; Auclair J; Dauvilliers Y; Côté I; Mathieu J; Gagnon C
Can J Neurol Sci; 2022 Mar; 49(2):287-290. PubMed ID: 33875033
[TBL] [Abstract][Full Text] [Related]
13. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.
Landfeldt E; Edström J; Jimenez-Moreno C; van Engelen BGM; Kirschner J; Lochmüller H
Patient; 2019 Aug; 12(4):365-373. PubMed ID: 30714084
[TBL] [Abstract][Full Text] [Related]
14. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
15. The myotonic dystrophy health index: Japanese adaption and validity testing.
Mori I; Fujino H; Matsumura T; Takada H; Ogata K; Nakamori M; Innami K; Shingaki H; Imura O; Takahashi MP; Heatwole C
Muscle Nerve; 2019 May; 59(5):577-582. PubMed ID: 30681157
[TBL] [Abstract][Full Text] [Related]
16. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability.
Laberge L; Gagnon C; Jean S; Mathieu J
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1403-5. PubMed ID: 16170085
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale.
Hermans MC; Hoeijmakers JG; Faber CG; Merkies IS
PLoS One; 2015; 10(10):e0139944. PubMed ID: 26484877
[TBL] [Abstract][Full Text] [Related]
19. Prospective measurement of quality of life in myotonic dystrophy type 1.
Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
[TBL] [Abstract][Full Text] [Related]
20. Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.
Heatwole C; Bode R; Johnson N; Dekdebrun J; Dilek N; Heatwole M; Hilbert JE; Luebbe E; Martens W; Mcdermott MP; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley R
Muscle Nerve; 2014 Jun; 49(6):906-14. PubMed ID: 24142420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
